Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Nutting

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Dental Update|March 14, 2012
Oral cancer: comprehending the condition, causes, controversies, control and consequences. 12. Radiotherapy and chemotherapyChristopher M Nutting, Crispian Scully
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Prostate cancer--the Royal Marsden conformal experienceChristopher M Nutting, David P Dearnaley
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?Kevin J Harrington, Christopher M Nutting
The Lancet. Oncology|May 4, 2010
Bravo for PRAVOKevin J Harrington, Christopher M Nutting
Oral Oncology|November 10, 2018
Patterns of failure, treatment outcomes and late toxicities of head and neck cancer in the current era of IMRTDorothy M Gujral, Christopher M Nutting
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 21, 2007
Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary siteShreerang Bhide, Catherine Clark, Kevin Harrington, et al.
International Journal of Surgery (London, England)|July 20, 2020
Invited commentary on "Initial surgical versus non-surgical treatments for advanced hypopharyngeal cancer; a meta-analysis with trial sequential analysis" (Int J Surg 2020; Epub ahead of print)James A McCaul, Paul C Nankivell, Christopher M Nutting
The British Journal of Oral & Maxillofacial Surgery|January 7, 2004
Re: Rowland NH and Schnetler JF. Primary malignant melanoma arising in the dorsum of the tongueK J Harrington, Christopher M Nutting, Daniel J Archer
The New England Journal of Medicine|March 8, 2008
Treatment of head and neck cancerChristopher M Nutting, Shreerang A Bhide, Kevin J Harrington
Cancer Metastasis Reviews|March 24, 2005
Gene therapy for head and neck cancerKevin J Harrington, Christopher M Nutting, Hardev S Pandha
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Dental Update|March 14, 2012
Oral cancer: comprehending the condition, causes, controversies, control and consequences. 12. Radiotherapy and chemotherapyChristopher M Nutting, Crispian Scully
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Prostate cancer--the Royal Marsden conformal experienceChristopher M Nutting, David P Dearnaley
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?Kevin J Harrington, Christopher M Nutting
The Lancet. Oncology|May 4, 2010
Bravo for PRAVOKevin J Harrington, Christopher M Nutting
Oral Oncology|November 10, 2018
Patterns of failure, treatment outcomes and late toxicities of head and neck cancer in the current era of IMRTDorothy M Gujral, Christopher M Nutting
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 21, 2007
Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary siteShreerang Bhide, Catherine Clark, Kevin Harrington, et al.
International Journal of Surgery (London, England)|July 20, 2020
Invited commentary on "Initial surgical versus non-surgical treatments for advanced hypopharyngeal cancer; a meta-analysis with trial sequential analysis" (Int J Surg 2020; Epub ahead of print)James A McCaul, Paul C Nankivell, Christopher M Nutting
The British Journal of Oral & Maxillofacial Surgery|January 7, 2004
Re: Rowland NH and Schnetler JF. Primary malignant melanoma arising in the dorsum of the tongueK J Harrington, Christopher M Nutting, Daniel J Archer
The New England Journal of Medicine|March 8, 2008
Treatment of head and neck cancerChristopher M Nutting, Shreerang A Bhide, Kevin J Harrington
Cancer Metastasis Reviews|March 24, 2005
Gene therapy for head and neck cancerKevin J Harrington, Christopher M Nutting, Hardev S Pandha
Pageof 11